by Paul Krzyzanowski | Sep 10, 2013
. Earlier this summer I had the fortunate opportunity to speak with Dr. Michael West, of BioTime, and pick his brain on various aspects of the stem cell industry, what it’s faced, and where it might go. It was a perfect follow up to my post in March that explored...
by Nick Dragojlovic | Jul 23, 2013
Would you use/support crowdfunding for research? Take the survey at the end of this post. . Biomedical research is expensive, and existing sources of funding often fall short. Profitable business models for the development of cell-based therapies are still being...
by David Brindley | Jul 9, 2013
. At the close of ISSCR2013, I left Boston bathed in an ochre sunset, and settled on a plane to reflect on what my most unexpected learning had been. My plane was bound not for home (London), but for Istanbul, where the TERMIS meeting was about to begin. As far as I’m...
by Paul Krzyzanowski | Jul 3, 2013
George Daley (File photo) Immediately after last month’s ISSCR meeting, George Daley travelled to the University of Toronto where he had been invited to be an external reviewer on a PhD thesis defense. While there, Daley spoke to a packed audience interested in what...
by Holly Wobma | Jun 18, 2013
True synthetic blood is coming, but it won’t be packaged like this. We’ve all heard the idiom “it’s in my blood”. For me, this applies to hockey and rock climbing. And a quick survey of my class suggests that everything from Southern BBQ sauce and ice...
by David Brindley | Jun 14, 2013
. The sheer scale of ISSCR 2013, which has attracted almost four thousand delegates, and the proficiency with which it is run, is a major achievement by its organizer and lead sponsor: the International Society for Stem Cell Research and the Harvard Stem Cell...
Comments